http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104758245-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
| filingDate | 2015-03-10^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-07-21^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-07-21^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104758245-B |
| titleOfInvention | A kind of Cefquinome sulfate oiliness suspension injection and preparation method thereof |
| abstract | The invention belongs to pharmaceutical technology field, and in particular to a kind of Cefquinome sulfate oiliness suspension injection and preparation method thereof, and the 100ml parenteral solutions include following component：0.1 ~ 10.0g of Cefquinome sulfate, 0.05 ~ 0.5g of antioxidant, 1.0 ~ 3.0g of bacteriostatic agent, 0.5 ~ 7.0g of emulsifying agent, 0.1 ~ 5.0g of suspending agent, 0.1 ~ 1.0g of thixotropic agent, surplus is oil for injection, and preparation method comprises the following steps：Suspending agent is distributed in a part of oil for injection, antioxidant, bacteriostatic agent is sequentially added, stirred, emulsifier for mixing is added, obtains solution system；Cefquinome sulfate is added in a part of oil for injection, grinds, obtains solution system；Two kinds of solution system mixing, oil for injection is settled to 100ml；Sterilizing, thus obtaining the product.The parenteral solution of the present invention and the newborn vaccine compatibility compatibility of the conventional oil of livestock and poultry are good, can close pin injection and reduce workload；Syringeability is good, and slow releasing function is obvious. |
| priorityDate | 2015-03-10^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 65 of 65.